Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) signed an agreement to acquire 15% stake in Fujian Sunvet Biotechnology Co., Ltd. from Guo Haiyan and 16 natural person shareholders for CNY 63 million on March 21, 2023. Tianjin Ringpu Bio-Technology will acquire 11.89% stake in Fujian Sunvet Biotechnology from Guo Haiyan and Tianjin Ringpu Bio-Technology will acquire 3.11% stake in Fujian Sunvet Biotechnology from 16 natural person shareholders. Fujian Sunvet Biotechnology will use own fund for the acquisition.

Fujian Sunvet Biotechnology has reported total assets of CNY 401.0548 million, net assets of CNY 126.957 million and net loss of CNY 24.1752 million on December 31, 2022. As per terms of agreement, Tianjin Ringpu Bio-Technology shall pay Guo Haiyan and 16 other persons the first equity transfer price of CNY 24.9776 million within 10 working days from the effective date of this agreement, Within 15 working days from the date Guo Haiyan and 16 other persons receives the aforementioned equity transfer price, Guo Haiyan and 16 other persons and Fujian Sunvet Biotechnology shall cooperate with Tianjin Ringpu Bio-Technology to complete the industrial and commercial change registration for the target equity. Within 10 working days from the date of completion of the aforementioned industrial and commercial change registration, Tianjin Ringpu Bio-Technology shall pay Guo Haiyan and 16 other persons the remaining equity transfer price of CNY 24.9776 million.